![Eddie J. Gray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eddie J. Gray
Président chez
Spybiotech Ltd.
Profil
Eddie J.
Gray currently works at Spybiotech Ltd., as Chairman from 2023, British Pharma Group Ltd., as Director, and Independent Press Standards Organisation CIC, as Director.
Mr. Gray also formerly worked at Dynavax Technologies Corp., as Chief Executive Officer & Director from 2013 to 2019, GlaxoSmithKline LLC, as VP & Director-Anti Infectives Marketing, Smithkline Beecham Pharmaceuticals (Canada), as VP & Director-Anti Infectives Marketing from 1988 to 2000, Genelabs Technologies, Inc., as President-European Pharmaceuticals, and GSK Plc, as President-European Pharmaceuticals from 2009 to 2013.
Mr. Gray received his undergraduate degree from the University of London and Masters Business Admin degree from Cranfield School of Management.
Postes actifs de Eddie J. Gray
| Sociétés | Poste | Début |
|---|---|---|
British Pharma Group Ltd. | Directeur/Membre du Conseil | 11/02/2011 |
Spybiotech Ltd.
 Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Président | 13/02/2023 |
Independent Press Standards Organisation CIC
 Independent Press Standards Organisation CIC General GovernmentGovernment Operates as regulatory body for British printed newspapers and magazines | Directeur/Membre du Conseil | - |
Anciens postes connus de Eddie J. Gray
| Sociétés | Poste | Fin |
|---|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Directeur Général | 01/08/2019 |
| GSK PLC | Corporate Officer/Principal | 01/01/2013 |
Smithkline Beecham Pharmaceuticals (Canada) | Sales & Marketing | 01/01/2000 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Corporate Officer/Principal | - |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Sales & Marketing | - |
Formation de Eddie J. Gray
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products and performs life science research and development | Health Technology |
Dynavax Technologies Corp.
 Dynavax Technologies Corp. BiotechnologyHealth Technology Develops and commercializes novel products to prevent and treat infectious diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
British Pharma Group Ltd. | |
Independent Press Standards Organisation CIC
Independent Press Standards Organisation CIC General GovernmentGovernment Operates as regulatory body for British printed newspapers and magazines | Government |
Smithkline Beecham Pharmaceuticals (Canada) | |
Cranfield School of Management
 Cranfield School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spybiotech Ltd.
Spybiotech Ltd. BiotechnologyHealth Technology Develops a molecular superglue which it believes can be used to create vaccines | Health Technology |
